ACCORD
Action to Control Cardiovascular Risk in Diabetes
|
Status:
This study is ongoing, but not recruiting participants.
Purpose:
To evaluate 3 complementary medical treatment strategies for type 2 diabetes to enhance the options for reducing the very high rate of major Cardiovascular Disease (CVD) morbidity and mortality.
Location(s):
United States, Canada
Year Started:
1999
Design:
A randomized, multicenter, double 2 X 2 factorial design.
Inclusion Criteria
Patients 40 years or olders with a history of clinical cardiovascular disease or patients 55 years or older without a history of clinical cardiovascular disease but considered at high risk of CVD event diagnosed with Type 2 diabetes.
Exclusion Criteria
Patients who have conditions that will reduce the safety or benefits of the ACCORD procedures. Patients who are not able to follow ACCORD procedures of taking the prescribed medications, going to clinic visits, and following health tips given.
Patient Involvement:
Patients will be randomly assigned to either a standard or aggressive control of blood sugar, then based on their blood pressure and cholesterol levels, assigned to one of the other two groups.
Primary Outcome:
Lowered risk of CVD in each of the 3 medical treatment strategies: lowered blood sugar, lowered blood pressure (<120mmHg systolic), blood fats (lower LDL and increase HDL).
Secondary Outcome:
Total mortality.
Source of Information:
Press. ACCORD Website.
ClinicalTrials.gov
|
|
Web Links and Publications:
|
|
This information last updated on: 12/30/2008
Reviewed on: 06/19/2009.
|
Trials
Directories